drugset / Trial / NCT04311099

Optimal Peripheral Nerve Block After Minimally Invasive Colon Surgery

NCT04311099 ↗

Phase 4 Completed 360 enrolled Claus Anders Bertelsen, PhD, MD
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the trial is to identify the "most simple non-inferior of three different methods", placebo, laparoscopic assisted transverse abdominal plane block (L-TAP) and ultrasound guided TAP block (US-TAP), using postoperative opioid consumption as a measure of efficacy in patients undergoing elective minimally invasive colon surgery in an ERAS setting. Postoperative pain scores and length of stay (LOS) will also be measured. The simplicity of the three methods is ranked as: 1) placebo, 2) L-TAP and 3) US-TAP.

Timeline

Start
2021-01-14
Primary completion
2024-02-08
Completion
2024-03-31

Outcome

Mixed primary results

paper The US-TAP block was no different from placebo at -1.4 mg morphine (97.5% CI -6.8 to 4.0 mg; p=0.55). PMID 39542642 ↗

paper The L-TAP block was superior to placebo at -5.9 mg morphine (97.5% CI -11.3 to -0.5 mg; p=0.01) PMID 39542642 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 2 mg/ml Other

Indications